Screening compound: HRFDCJFRHJTJEO-UHFFFAOYSA-N

Screening compound: HRFDCJFRHJTJEO-UHFFFAOYSA-N
Screening compound: HRFDCJFRHJTJEO-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
HRFDCJFRHJTJEO-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M215-0250

Molecular Formula

C27H31FN4O2S (C27 H31 FN4 O2 S)

Compound Name

N~4~-[2-(1-cyclohexenyl)ethyl]-1-[3-(4-fluorobenzyl)-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-piperidinecarboxamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-1-{3-[(4-fluorophenyl)methyl]-4-oxo-3H4H-thieno[32-d]pyrimidin-2-yl}piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1C(N(Cc(cc1)ccc1F)C1=O)=Nc2c1scc2)NCCC1=CCCCC1

InChI

InChI=1S/C27H31FN4O2S/c28-22-8-6-20(7-9-22)18-32-26(34)24-23(13-17-35-24)30-27(32)31-15-11-21(12-16-31)25(33)29-14-10-19-4-2-1-3-5-19/h4,6-9,13,17,21H,1-3,5,10-12,14-16,18H2,(H,29,33)

InChI Key

HRFDCJFRHJTJEO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD22592649

HRFDCJFRHJTJEO-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Kinases
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with HRFDCJFRHJTJEO-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound HRFDCJFRHJTJEO-UHFFFAOYSA-N?
Check Price and Availability of HRFDCJFRHJTJEO-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of HRFDCJFRHJTJEO-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for HRFDCJFRHJTJEO-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for HRFDCJFRHJTJEO-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of HRFDCJFRHJTJEO-UHFFFAOYSA-N available by request